Global allergy immunotherapies market 2024-2028

Description

List of Tables

The allergy immunotherapies market is forecasted to grow by USD 1189 mn during 2023-2028, accelerating at a CAGR of 9.62% during the forecast period. The report on the allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, recent approvals and a strong pipeline, and growing market consolidation.

Technavio's allergy immunotherapies market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.55%
CAGR	9.62%
Incremental Value	$1189mn

By Product

SCIT
SLIT

By Type

Allergic Rhinitis
Asthma
Food Allergy
Others

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the technological advances in allergy diagnostics as one of the prime reasons driving the allergy immunotherapies market growth during the next few years. Also, emerging drug development technologies and growing popularity of slit will lead to sizable demand in the market.

The report on the allergy immunotherapies market covers the following areas:

Allergy immunotherapies market sizing
Allergy immunotherapies market forecast
Allergy immunotherapies market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy immunotherapies market vendors that include Adamis Pharmaceuticals Corp., Aimmune Therapeutics Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLC, , Biomay AG, DBV Technologies SA, Desentum Oy, HAL Allergy BV, Immunomic Therapeutics Inc., Jubilant Pharmova Ltd., LETI Pharma SLU, LOFARMA Spa, Merck KGaA, Novartis AG, Optum Inc., SHIONOGI Co. Ltd., Stallergenes Greer Ltd., Torii Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the allergy immunotherapies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR41320

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Allergy Immunotherapies Market 2018 - 2022
- Historic Market Size - Data Table on Global Allergy Immunotherapies Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
6.3 SCIT - Market size and forecast 2023-2028
- Chart on SCIT - Market size and forecast 2023-2028 ($ million)
- Data Table on SCIT - Market size and forecast 2023-2028 ($ million)
- Chart on SCIT - Year-over-year growth 2023-2028 (%)
- Data Table on SCIT - Year-over-year growth 2023-2028 (%)
6.4 SLIT - Market size and forecast 2023-2028
- Chart on SLIT - Market size and forecast 2023-2028 ($ million)
- Data Table on SLIT - Market size and forecast 2023-2028 ($ million)
- Chart on SLIT - Year-over-year growth 2023-2028 (%)
- Data Table on SLIT - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
7.3 Allergic Rhinitis - Market size and forecast 2023-2028
- Chart on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
- Data Table on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
- Chart on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
- Data Table on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
7.4 Asthma - Market size and forecast 2023-2028
- Chart on Asthma - Market size and forecast 2023-2028 ($ million)
- Data Table on Asthma - Market size and forecast 2023-2028 ($ million)
- Chart on Asthma - Year-over-year growth 2023-2028 (%)
- Data Table on Asthma - Year-over-year growth 2023-2028 (%)
7.5 Food Allergy - Market size and forecast 2023-2028
- Chart on Food Allergy - Market size and forecast 2023-2028 ($ million)
- Data Table on Food Allergy - Market size and forecast 2023-2028 ($ million)
- Chart on Food Allergy - Year-over-year growth 2023-2028 (%)
- Data Table on Food Allergy - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.8 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Adamis Pharmaceuticals Corp.
- Adamis Pharmaceuticals Corp. - Overview
- Adamis Pharmaceuticals Corp. - Business segments
- Adamis Pharmaceuticals Corp. - Key offerings
- Adamis Pharmaceuticals Corp. - Segment focus
12.4 Aimmune Therapeutics Inc.
- Aimmune Therapeutics Inc. - Overview
- Aimmune Therapeutics Inc. - Product / Service
- Aimmune Therapeutics Inc. - Key offerings
12.5 ALK Abello AS
- ALK Abello AS - Overview
- ALK Abello AS - Business segments
- ALK Abello AS - Key offerings
- ALK Abello AS - Segment focus
12.6 Allergy Therapeutics PLC
- Allergy Therapeutics PLC - Overview
- Allergy Therapeutics PLC - Product / Service
- Allergy Therapeutics PLC - Key offerings
12.7 DBV Technologies SA
- DBV Technologies SA - Overview
- DBV Technologies SA - Product / Service
- DBV Technologies SA - Key offerings
12.8 Desentum Oy
- Desentum Oy - Overview
- Desentum Oy - Product / Service
- Desentum Oy - Key offerings
12.9 HAL Allergy BV
- HAL Allergy BV - Overview
- HAL Allergy BV - Key offerings
12.10 Immunomic Therapeutics Inc.
- Immunomic Therapeutics Inc. - Overview
- Immunomic Therapeutics Inc. - Product / Service
- Immunomic Therapeutics Inc. - Key offerings
12.11 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
12.12 LETI Pharma SLU
- LETI Pharma SLU - Overview
- LETI Pharma SLU - Product / Service
- LETI Pharma SLU - Key offerings
12.13 LOFARMA Spa
- LOFARMA Spa - Overview
- LOFARMA Spa - Product / Service
- LOFARMA Spa - Key offerings
12.14 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
12.15 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
12.16 Stallergenes Greer Ltd.
- Stallergenes Greer Ltd. - Overview
- Stallergenes Greer Ltd. - Product / Service
- Stallergenes Greer Ltd. - Key offerings
12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations